-
公开(公告)号:US20220105050A1
公开(公告)日:2022-04-07
申请号:US17066957
申请日:2020-10-09
申请人: Epalex Corporation
发明人: Michael A. Rogawski , Enrique Carrazana , Edward Brendan Magrab , Steven L. Krill , Allen Heller
摘要: The present disclosure pertains to the use of propofol prodrugs, pharmaceutically acceptable salts of propofol prodrugs, or mixtures thereof, to treat migraine.
-
公开(公告)号:US20220265686A1
公开(公告)日:2022-08-25
申请号:US17686738
申请日:2022-03-04
申请人: Epalex Corporation
IPC分类号: A61K31/661 , A61K9/20 , A61K9/00 , A61K47/12
摘要: The present disclosure pertains to the use of fospropofol, pharmaceutically acceptable salts of fospropofol, or mixtures thereof. Pharmaceutical compositions comprising fospropofol, pharmaceutically acceptable salts of fospropofol, or mixtures thereof, and methods of treating diseases or disorders, including migraine are also disclosed.
-